These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29543337)

  • 1. Utility of the Outcome Questionnaire-45.2 in outpatient anxiety clinics: A comparison between anxiety patients with and without co-occurring depression.
    Levy HC; Billingsley AL; Springer KS; Hannan S; Das A; Tolin DF
    J Clin Psychol; 2018 Sep; 74(9):1570-1582. PubMed ID: 29543337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Korean validation study of the Clinically Useful Anxiety Outcome Scale: Comorbidity and differentiation of anxiety and depressive disorders.
    Jeon SW; Han C; Ko YH; Yoon S; Pae CU; Choi J; Kim JM; Yoon HK; Lee H; Patkar AA; Zimmerman M
    PLoS One; 2017; 12(6):e0179247. PubMed ID: 28604808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring patient distress in primary care.
    Seelert KR; Hill RD; Rigdon MA; Schwenzfeier E
    Fam Med; 1999; 31(7):483-7. PubMed ID: 10425529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Four-Dimensional Symptom Questionnaire (4DSQ) in the general population: scale structure, reliability, measurement invariance and normative data: a cross-sectional survey.
    Terluin B; Smits N; Brouwers EP; de Vet HC
    Health Qual Life Outcomes; 2016 Sep; 14(1):130. PubMed ID: 27629535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of prolonged treatment course for depressive and anxiety disorders in an outpatient setting: The Leiden routine outcome monitoring study.
    Boer S; Dekkers OM; Cessie SL; Carlier IV; van Hemert AM
    J Affect Disord; 2019 Mar; 247():81-87. PubMed ID: 30658244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric disorders and functional disability in outpatients with traumatic brain injuries.
    Fann JR; Katon WJ; Uomoto JM; Esselman PC
    Am J Psychiatry; 1995 Oct; 152(10):1493-9. PubMed ID: 7573589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Patients without DSM-IV-disorders and/or subclinical symptoms in generalistic and specialised mental health care].
    Kloos MW; Tiemens BG; Hutschemaekers GJ
    Tijdschr Psychiatr; 2016; 58(8):565-73. PubMed ID: 27527882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome and impact of mental disorders in primary care at 5 years.
    Jackson JL; Passamonti M; Kroenke K
    Psychosom Med; 2007 Apr; 69(3):270-6. PubMed ID: 17401055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.
    Graystone HJ; Garner MJ; Baldwin DS
    J Affect Disord; 2009 Apr; 114(1-3):305-9. PubMed ID: 18656267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for anxiety and depression: reassessing the utility of the Zung scales.
    Dunstan DA; Scott N; Todd AK
    BMC Psychiatry; 2017 Sep; 17(1):329. PubMed ID: 28886698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a Web-Based Guided Self-help Intervention for Outpatients With a Depressive Disorder: Short-term Results From a Randomized Controlled Trial.
    Kenter RM; Cuijpers P; Beekman A; van Straten A
    J Med Internet Res; 2016 Mar; 18(3):e80. PubMed ID: 27032449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive negative thinking as a predictor of depression and anxiety: A longitudinal cohort study.
    Spinhoven P; van Hemert AM; Penninx BW
    J Affect Disord; 2018 Dec; 241():216-225. PubMed ID: 30138805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distress and functioning in mixed anxiety and depressive disorder.
    Małyszczak K; Pawłowski T
    Psychiatry Clin Neurosci; 2006 Apr; 60(2):168-73. PubMed ID: 16594940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
    Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorder.
    Zimmerman M; Chelminski I; Young D; Dalrymple K; Walsh E; Rosenstein L
    J Clin Psychiatry; 2014 Jun; 75(6):601-7. PubMed ID: 24813209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age differences in symptoms of depression and anxiety: examining behavioral medicine outpatients.
    Goldberg JH; Breckenridge JN; Sheikh JI
    J Behav Med; 2003 Apr; 26(2):119-32. PubMed ID: 12776382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the emotion thermometers and hospital anxiety and depression scales in Singapore: Screening cancer patients for distress, anxiety and depression.
    Beck KR; Tan SM; Lum SS; Lim LE; Krishna LK
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e241-9. PubMed ID: 24673756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speaking a more consistent language when discussing severe depression: a calibration study of 3 self-report measures of depressive symptoms.
    Zimmerman M; Martinez JH; Friedman M; Boerescu DA; Attiullah N; Toba C
    J Clin Psychiatry; 2014 Feb; 75(2):141-6. PubMed ID: 24345406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability and validity of the DSM-5 Anxious Distress Specifier Interview.
    Zimmerman M; Clark H; McGonigal P; Harris L; Holst CG; Martin J
    Compr Psychiatry; 2017 Jul; 76():11-17. PubMed ID: 28384524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.